Quick Answer
MEDICINOVA INC reported Stockholders Equity of $41.59 million for fiscal year 2025.
MEDICINOVA INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $41.59M | -20.8% |
| 2024 | $52.50M | -15.8% |
| 2023 | $62.38M | -11.2% |
| 2022 | $70.24M | -16.1% |
| 2021 | $83.68M | +17.3% |
| 2020 | $71.33M | -4.8% |
| 2019 | $74.89M | +2.4% |
| 2018 | $73.11M | +89.2% |
| 2017 | $38.64M | +11.9% |
| 2016 | $34.53M | +5.4% |
| 2015 | $32.75M | +48.8% |
| 2014 | $22.01M | -13.4% |
| 2013 | $25.43M | +70.9% |
| 2012 | $14.88M | -36.7% |
| 2011 | $23.50M | -4.9% |
| 2010 | $24.70M | -38.3% |
| 2009 | $40.01M | -16.7% |
| 2008 | $48.04M | -27.9% |
| 2007 | $66.61M | -34.0% |
| 2006 | $100.98M | -25.6% |
| 2005 | $135.71M | +1669.5% |
| 2004 | $7.67M | +67.8% |
| 2003 | $4.57M | +307.1% |
| 2002 | $1.12M | -86.1% |
| 2001 | $8.05M | +66.1% |
| 2000 | $4.85M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $43.96M | -20.2% | -6.2% |
| June 30, 2025 | $46.86M | -18.4% | -6.2% |
| March 31, 2025 | $49.93M | -16.5% | -4.9% |
| December 31, 2024 | $52.50M | -15.8% | -4.7% |
| September 30, 2024 | $55.07M | -14.9% | -4.1% |
| June 30, 2024 | $57.41M | -11.9% | -4.1% |
| March 31, 2024 | $59.83M | -11.7% | -4.1% |
| December 31, 2023 | $62.38M | -11.2% | -3.5% |
- MEDICINOVA INC showed a decrease of -20.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2000–2025 period, MEDICINOVA INC’s stockholders equity has grown by 757.7% (from $4.85 million to $41.59 million).
- The most recent figure is from MEDICINOVA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: